Related Experiment Videos
Breast Surgery International--breast cancer in developing countries
K Sandelin1, J P Apffelstaedt, H Abdullah
1Department of Surgical Sciences Karolinska Institutet, Stockholm, Sweden. kerstin.sandelin@ks.se
Summary
Breast cancer care in developing nations faces significant challenges due to limited resources and unique patient demographics. Breast Surgery International aims to improve global breast cancer treatment through international collaboration and training.
Area of Science:
- Oncology
- Global Health
- Surgical Sciences
Background:
- Breast Surgery International (BSI) was established to advance breast surgery globally, with a focus on developing countries.
- Locally advanced breast cancer (LABC) presents distinct challenges in resource-limited settings.
- Disparities in diagnosis, management, and treatment exist due to socioeconomic and cultural barriers.
Purpose of the Study:
- To summarize the current situation of locally advanced breast cancer (LABC) in two African countries and Malaysia.
- To highlight the differences in LABC management compared to established international recommendations.
- To emphasize the need for tailored strategies and international collaboration in managing LABC in developing regions.
Main Methods:
- Edited summary of a symposium focused on LABC in developing countries.
- Analysis of diagnostic, management, and treatment disparities.
- Review of clinical characteristics, including younger age at onset and higher male incidence.
Main Results:
- Significant resource limitations, lack of facility access, and socioeconomic barriers impact LABC care.
- Clinical presentation often includes younger patients, a notable proportion of male cases, and predominantly locally advanced disease.
- Standard treatment modalities (chemotherapy, surgery, radiotherapy, hormonal therapy) require adaptation.
Conclusions:
- International collaboration through organizations like BSI is crucial for addressing LABC in developing countries.
- Training opportunities and collaborative research are vital for improving outcomes for the world's most common female malignancy.
- Tailored, rational treatment plans integrating chemotherapy, surgery, radiotherapy, and hormonal therapy are essential for LABC management.